MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

Chuangui Wang1, Alexey Ivanov, Lihong Chen

  • 1Molecular Oncology Program, H Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, FL 33612, USA.

The EMBO Journal
|August 19, 2005
PubMed

Insights

MDM2 interacts with KAP1, a nuclear corepressor, to regulate the p53 tumor suppressor. This interaction promotes p53 degradation, but ARF can disrupt it, stabilizing p53 and enhancing anti-cancer responses.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Regulation

Background:

  • MDM2 is a key E3 ligase regulating the p53 tumor suppressor protein.
  • MDM2 controls p53 stability and function through binding, inactivation, and degradation.
  • Understanding MDM2 regulation is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the interaction between MDM2 and the nuclear corepressor KAP1.
  • To elucidate the role of the MDM2-KAP1 complex in p53 regulation.
  • To explore the impact of ARF on this interaction and subsequent p53 activity.

Main Methods:

  • Co-immunoprecipitation to demonstrate MDM2-KAP1 binding.
  • RNA interference (RNAi) to deplete KAP1 expression.
  • Analysis of p53 acetylation, ubiquitination, and transcriptional activity.

Main Results:

  • MDM2 directly interacts with KAP1 via specific domains.
  • KAP1 enhances MDM2-mediated p53 ubiquitination and degradation.
  • ARF competes with KAP1 for MDM2 binding, reducing MDM2-KAP1 interaction.
  • KAP1 depletion increases p53 activity and apoptosis.

Conclusions:

  • The MDM2-KAP1 interaction is a novel mechanism for p53 functional regulation.
  • KAP1 acts as a co-regulator with MDM2 to suppress p53.
  • ARF's ability to disrupt KAP1-MDM2 binding offers a potential therapeutic strategy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...